Patents by Inventor Lina Weinschenk

Lina Weinschenk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Di- and triphosphate prodrugs
    Patent number: 10131685
    Abstract: Compounds which can be used as prodrugs, in particular nucleoside diphosphate and triphosphate prodrugs, and a method for producing these compounds. The aim is to provide improved di- and/or triphosphate prodrugs, in particular nucleotide or nucleotide analog prodrugs. This is achieved in one aspect by providing bioreversibly and asymmetrically masked di- and triphosphate compounds, in particular nucleoside diphosphate and nucleoside triphosphate compounds or the analogs thereof. The masking only occurs at the terminal phosphate, i.e. at the ?- or ?-phosphate, whereas the masking of the internal phosphate is omitted.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: November 20, 2018
    Assignee: Universitaet Hamburg
    Inventors: Chris Meier, Tristan Gollnest, Tobias Nack, Lina Weinschenk
  • DI- AND TRIPHOSPHATE PRODRUGS
    Publication number: 20170275328
    Abstract: Compounds which can be used as prodrugs, in particular nucleoside diphosphate and triphosphate prodrugs, and a method for producing these compounds. The aim is to provide improved di- and/or triphosphate prodrugs, in particular nucleotide or nucleotide analog prodrugs. This is achieved in one aspect by providing bioreversibly and asymmetrically masked di- and triphosphate compounds, in particular nucleoside diphosphate and nucleoside triphosphate compounds or the analogs thereof. The masking only occurs at the terminal phosphate, i.e. at the ?- or ?-phosphate, whereas the masking of the internal phosphate is omitted.
    Type: Application
    Filed: August 17, 2015
    Publication date: September 28, 2017
    Inventors: Chris Meier, Tristan Gollnest, Tobias Nack, Lina Weinschenk